GB0921731D0 - Theraputic uses - Google Patents

Theraputic uses

Info

Publication number
GB0921731D0
GB0921731D0 GBGB0921731.6A GB0921731A GB0921731D0 GB 0921731 D0 GB0921731 D0 GB 0921731D0 GB 0921731 A GB0921731 A GB 0921731A GB 0921731 D0 GB0921731 D0 GB 0921731D0
Authority
GB
United Kingdom
Prior art keywords
theraputic
theraputic uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0921731.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respivert Ltd
Original Assignee
Respivert Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Ltd filed Critical Respivert Ltd
Priority to GBGB0921731.6A priority Critical patent/GB0921731D0/en
Publication of GB0921731D0 publication Critical patent/GB0921731D0/en
Priority to TW099143134A priority patent/TW201130813A/en
Priority to UY0001033097A priority patent/UY33097A/en
Priority to PCT/GB2010/052066 priority patent/WO2011070368A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0921731.6A 2009-12-11 2009-12-11 Theraputic uses Ceased GB0921731D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0921731.6A GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses
TW099143134A TW201130813A (en) 2009-12-11 2010-12-10 Therapeutic uses
UY0001033097A UY33097A (en) 2009-12-11 2010-12-10 DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USES
PCT/GB2010/052066 WO2011070368A1 (en) 2009-12-11 2010-12-10 Antiviral use of urea compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921731.6A GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses

Publications (1)

Publication Number Publication Date
GB0921731D0 true GB0921731D0 (en) 2010-01-27

Family

ID=41666983

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0921731.6A Ceased GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses

Country Status (4)

Country Link
GB (1) GB0921731D0 (en)
TW (1) TW201130813A (en)
UY (1) UY33097A (en)
WO (1) WO2011070368A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA105763C2 (en) 2007-12-19 2014-06-25 Кансер Рісерч Текнолоджі Лімітед Pyrido[2,3-b]pyrazin-8-substituted compounds and use thereof
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
NZ706154A (en) 2010-02-01 2016-09-30 Cancer Rec Tech Ltd 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
GB201010193D0 (en) 2010-06-17 2010-07-21 Respivert Ltd Medicinal use
GB201010196D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Methods
EP2582700B1 (en) 2010-06-17 2016-11-02 Respivert Limited Respiratory formulations containing p38 mapk inhibitors
EP2578582A1 (en) * 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors
JP2014528404A (en) * 2011-10-03 2014-10-27 レスピバート・リミテツド 1-pyrazolyl-3- (4-((2-anilinopyrimidin-4-yl) oxy) naphthalen-1-yl) urea as a p38 MAP kinase inhibitor
PE20141370A1 (en) 2011-12-09 2014-10-17 Chiesi Farma Spa KINASE INHIBITORS
BR112014013177A2 (en) 2011-12-09 2017-06-13 Chiesi Farm Spa compound, pharmaceutical composition and use of a compound
GB201214750D0 (en) 2012-08-17 2012-10-03 Respivert Ltd Compounds
GB201215357D0 (en) 2012-08-29 2012-10-10 Respivert Ltd Compounds
EP2890460B1 (en) 2012-08-29 2017-02-22 Respivert Limited Kinase inhibitors
US9783556B2 (en) 2012-08-29 2017-10-10 Respivert Limited Kinase inhibitors
EP2890695A2 (en) 2012-08-29 2015-07-08 Respivert Limited Kinase inhibitors
EP2925742B1 (en) 2012-11-16 2016-10-26 Respivert Limited Kinase inhibitors
WO2014140582A1 (en) 2013-03-14 2014-09-18 Respivert Limited Kinase inhibitors
MX363949B (en) 2013-04-02 2019-04-08 Topivert Pharma Ltd Kinase inhibitor.
US9771353B2 (en) 2013-04-02 2017-09-26 Topivert Pharma Limited Kinase inhibitors based upon N-alkyl pyrazoles
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis
WO2015092423A1 (en) 2013-12-20 2015-06-25 Respivert Limited Urea derivatives useful as kinase inhibitors
EP3105222B1 (en) 2014-02-14 2018-04-11 Respivert Limited Aromatic heterocyclic compounds as antiinflammatory compounds
MA40774A (en) 2014-10-01 2017-08-08 Respivert Ltd DIARYLEUREA DERIVATIVES AS KINASE P38 INHIBITORS
CA3015978A1 (en) 2016-04-06 2017-10-12 Topivert Pharma Limited Kinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
JP4629978B2 (en) * 2002-02-25 2011-02-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 1,4-Disubstituted benzofused cycloalkylurea compounds useful for the treatment of cytokine-mediated diseases
JP5094716B2 (en) 2005-06-20 2012-12-12 テイボテク・フアーマシユーチカルズ Heterocyclylaminoalkyl-substituted benzimidazoles
ES2378704T3 (en) 2006-01-27 2012-04-17 Array Biopharma, Inc. Glucokinase activators
CN101374841A (en) 2006-01-30 2009-02-25 Irm责任有限公司 Spiroimidazole Derivatives as PPAR Modulators
WO2007096764A2 (en) 2006-02-27 2007-08-30 Glenmark Pharmaceuticals S.A. Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
WO2010067130A1 (en) * 2008-12-11 2010-06-17 Respivert Limited P38 map kinase inhibitors

Also Published As

Publication number Publication date
WO2011070368A1 (en) 2011-06-16
UY33097A (en) 2011-06-30
TW201130813A (en) 2011-09-16

Similar Documents

Publication Publication Date Title
GB0921731D0 (en) Theraputic uses
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
GB0919432D0 (en) Use
DK2442650T4 (en) Sublingualt apomorfin
EP2462514A4 (en) Greenbooks
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
GB2482817B (en) Novel use
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
GB0922505D0 (en) Use
GB0905864D0 (en) Novel use
GB0900319D0 (en) Hydrocharger
GB0917304D0 (en) Use
EP2510125A4 (en) Hyperprimers
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4926P (en) Bonscalib Scaevola aemula
GB0919586D0 (en) Use
GB0907472D0 (en) Use
GB0907963D0 (en) Use
GB0919888D0 (en) Use
GB0912237D0 (en) Use
GB201206482D0 (en) #magnotherapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)